ArticleBlood advances2022

Impact of ruxolitinib on survival of patients with myelofibrosis in the real world: update of the ERNEST Study.

Paola Guglielmelli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.